We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.82%
2 Technology 2.79%
3 Financials 2.26%
4 Consumer Discretionary 1.92%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TA
14501
PUT
DELISTED
TravelCenters of America LLC
TA
-8,300
Closed -$357K
VYNT
14502
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
-7,037
Closed -$50K
MIMO.WS
14503
DELISTED
Airspan Networks Holdings Inc Warrants
MIMO.WS
-144,936
Closed -$50K
IMV
14504
CALL
DELISTED
IMV Inc. Common Shares
IMV
-3,900
Closed -$55K
SVNA
14505
DELISTED
7 Acquisition Corp
SVNA
-300,000
Closed -$2.98M
TGR.U
14506
DELISTED
Kimbell Tiger Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
TGR.U
-502,410
Closed -$5.09M
JNCE
14507
PUT
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-16,200
Closed -$110K
BSMX
14508
PUT
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
-13,500
Closed -$71K
ADALW
14509
DELISTED
Anthemis Digital Acquisitions I Corp Warrant
ADALW
-87,838
Closed -$23K
TRAQ
14510
DELISTED
Trine II Acquisition Corp.
TRAQ
-1,344,893
Closed -$13.4M
SKYA
14511
DELISTED
Skydeck Acquisition Corp. Class A Ordinary Shares
SKYA
-348,600
Closed -$3.39M
IQMDW
14512
DELISTED
Intelligent Medicine Acquisition Corp. Warrant
IQMDW
-300,000
Closed -$83K
IQMD
14513
DELISTED
Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
-600,000
Closed -$6M
ML
14514
DELISTED
MoneyLion Inc.
ML
-3,447
Closed -$183K
PEAR
14515
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
-116,701
Closed -$589K
DHR.PRB
14516
DELISTED
Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B
DHR.PRB
-142
Closed -$224K
YTPG
14517
DELISTED
TPG Pace Beneficial II Corp.
YTPG
-1,064,595
Closed -$10.5M
DTEA
14518
CALL
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
-30,200
Closed -$85K
AGRX
14519
CALL
DELISTED
Agile Therapeutics
AGRX
-38
Closed -$16K
AGRX
14520
DELISTED
Agile Therapeutics
AGRX
-13
Closed -$5K
GLS
14521
DELISTED
Gelesis Holdings, Inc.
GLS
-79,828
Closed -$361K
DMYS.WS
14522
DELISTED
dMY Technology Group, Inc. VI Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
DMYS.WS
-350,136
Closed -$242K
CDAK
14523
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
-32,045
Closed -$113K
CDAK
14524
PUT
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
-10,200
Closed -$64K
IDHD
14525
DELISTED
Invesco S&P International Developed High Dividend Low Volatility ETF
IDHD
-13,101
Closed -$347K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.